Primary liver cancer is one of the most severe cancer burdens around the world. Metabolic
reprogramming is one phenotype of cancer, and blood metabolic markers are closely …

Hepatocellular carcinoma (HCC) has high incidence and mortality rates and poor prognosis
and greatly threatens human health. Early identification and diagnosis is an important …

Metabolic reprogramming has been identified as a hallmark of cancer. Liver is an essential
hub in the body for the metabolism of three major nutrients including glucose, lipids and …

Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed
at late and advanced stages. Currently, limited and insensitive diagnostic modalities …

Background Correct staging of hepatocellular carcinoma (HCC) could help physicians to
precisely select treatments for patients, such as surgery, chemotherapy, or their combination …

Abstract Treatment effectiveness in hepatocellular carcinoma (HCC) depends on early
detection and precision-medicine-based patient stratification for targeted therapies …

Many hepatocellular carcinoma (HCC) patients suffer from late stages when diagnosed,
leading to dismal prospects for cure. Improving the diagnosis and treatment of HCC remains …

Comprehensive prognostic risk prediction of hepatocellular carcinoma (HCC) after surgical
treatment is particularly important for guiding clinical decision-making and improving …

Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer, with
increasing prevalence worldwide. The mortality rate of HCC is similar to its incidence rate …

Patients with chronic liver diseases (CLD) including chronic hepatitis B and hepatic cirrhosis
(CIR) are the major high-risk population of hepatocellular carcinoma (HCC). The differential …